David Rush

6PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)AutoimmunityNeonatologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 09, 2024
Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients.

Christie Rampersad, Chris Wiebe, Robert Balshaw

|Oct 30, 2021
The negative impact of T cell-mediated rejection on renal allograft survival in the modern era.

Christie Rampersad, Robert Balshaw, Ian W Gibson

|Oct 14, 2020
i-IFTA and chronic active T cell-mediated rejection: A tale of 2 (DeKAF) cohorts.

Erika S Helgeson, Roslyn Mannon, Joseph Grande

|Oct 09, 2020
Validity and utility of urinary CXCL10/Cr immune monitoring in pediatric kidney transplant recipients.

Tom D Blydt-Hansen, Atul Sharma, Ian W Gibson

|Sep 21, 2020
A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation.

Peter W Nickerson, Robert Balshaw, Chris Wiebe

|Mar 19, 2020
Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection.

Chris Wiebe, David N Rush, Ian W Gibson

Pageof 1